[ad_1]
The government failed to secure enough supplies early
Evasion of Liability Issuance While Advocating for Safety
Experts “Introduction first is aggressively
Safety is an issue to highlight at the time of vaccination “
On the 22nd (local time), officials from the virus research institute in Belgrade, Serbia, are unloading the first quantity of Pfizer-Bioentech’s Corona 19 vaccine from a truck. Belgrade Reuters = Yonhap News
The government was in no rush to negotiate to secure a vaccine without predicting the third Corona 19 epidemic, and this raises anxiety that it does not know when enough vaccines can be introduced. As the controversy escalated into a furious wave, the government actively defended itself, saying that verifying “vaccine safety” was a priority. However, infectious disease experts noted that vaccine safety is an issue that should be highlighted not at the time of introduction, but at the time of vaccination, and that the government is only urgently avoiding liability for not secure early quantities. On the 23rd, Sohn Young-rae, Head of the Accident Recovery Headquarters Strategic Planning Division (heavy water version), in a regular briefing, said: “As a quarantine authority, we express great concern about creating a social atmosphere that seems to compete for first place, as if it were the first in the world to receive a vaccine. Revealed. “The development process for the Corona 19 vaccine has been shortened considerably, so safety (verification) is important.” I am very fortunate to have the opportunity to observe the problems that occur in the country where the vaccine is administered for the first time for a month or two. In a situation where doubts are growing about the timing of the introduction of the vaccine in Korea, he took the ‘long answer from the document’ that ‘vaccination may come a little late’. The government previously announced that it had secured a vaccine for 44 million people through the COVAX Facility, an international organization for joint purchasing of vaccines, and foreign pharmaceutical companies AstraZeneca, Pfizer, Modena and Janssen. However, the introduction time in Korea is specified from February to March next year, and AstraZeneca is the only vaccine that has completed a purchase contract. The government plans to conclude an actual contract with Pfizer and Janssen this month and with Modena in January next year, but it is difficult to reveal the timing of the introduction due to confidentiality provisions with individual drug companies. Some outlets reported that “of the 10 million supplies of AstraZeneca vaccines, only 750,000 are supplied in February and March,” for the same reason. Despite such a situation, the government seems to walk away from the controversy by re-emphasizing only that the situation in the United States, Europe and Korea was different. “In fact, there are not many quarantine strategies that can be adopted other than vaccines in countries like the United States, so we have been putting all our efforts into vaccines,” Son said, dismissed, saying: “It is somewhat inappropriate that Let’s take these countries as teachers on the other hand. ” . However, it is not known when the peak of the third outbreak is now known, so it seems difficult for the government to alleviate public anxiety just by emphasizing “security check.” Choi Won-seok, professor at the Ansan Hospital of Korea University (department of infectious medicine), said: “There have been no reports of adverse side effects that are serious enough to stop vaccination during the overseas vaccination process. “. It is not a problem that determines the time of inoculation, so it is appropriate to be aggressive in the introduction. He added: “Recently, government critics often seem to question the safety of AstraZeneca vaccines, and governments and ruling parties are often concerned about the safety of vaccines from other pharmaceutical companies.” “It can happen, and as a result, even the most difficult vaccines can be used.” Some suggest that the government should be able to properly assess the response so far, so future vaccine introduction plans should be more aggressive. Eom Joong-sik, professor at Gachon University Gil Hospital (infectious medicine department), said: “We need to have the government decision-making structure, legal and institutional mechanisms and the authority to secure budgets that can pre-purchase with courage the vaccines in development, so that future negotiations on the introduction of vaccines will be easier. I’m going to. “By Choi Ha-yan, Staff Reporter [email protected]
[ad_2]
